DG
DXCM icon

David Greenspan’s DexCom DXCM Stock Holding History

David Greenspan’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-632,000
Closed -$78.4M – 67
2023
Q4 		$78.4M Buy
+632,000
New +$64.6M 1.74% 25
2018
Q2 		– Sell
-372,000
Closed -$6.9M – 20
2018
Q1 		$6.9M Buy
372,000
+92,000
+33% +$1.36M 0.44% 24
2017
Q4 		$4.02M Sell
280,000
-92,000
-25% -$1.2M 0.4% 19
2017
Q3 		$4.55M Buy
+372,000
New +$6.58M 0.24% 20
2017
Q2 		– Sell
-4,478,000
Closed -$94.9M – 17
2017
Q1 		$94.9M Buy
+4,478,000
New +$87.4M 4.64% 12

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

David Greenspan's DXCM Position: Q1 2024 in Review

David Greenspan sold out of DexCom (DXCM) in Q1 2024, closing a stake of 632,000 shares — an estimated $78.4M sold.

David Greenspan first reported a position in DXCM in Q1 2017 and held it in 5 quarters. The position peaked at $94.9M in Q1 2017. 1,033 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • David Greenspan reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • David Greenspan sold 632,000 DexCom shares in Q1 2024, an estimated $78.4M.
  • David Greenspan first reported a position in DexCom in Q1 2017 and held it in 5 quarters.
  • David Greenspan's DexCom position peaked at $94.9M in Q1 2017.
  • 1,033 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Slate Path Capital's 13F filing for Q1 2024, filed 15 May 2024.